Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Experimmune,
A Center for Immunotherapeutic Development,
Department of Immunotherapeutics and Biotechnology,
Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology
Oriana E. Hawkins has not added Biography.
If you are Oriana E. Hawkins and would like to personalize this page please email our Author Liaison for assistance.
Identification of breast cancer peptide epitopes presented by HLA-A*0201.
Journal of proteome research Apr, 2008 | Pubmed ID: 18345606
Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2009 | Pubmed ID: 19494300
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties.
Cancer immunology, immunotherapy : CII Apr, 2010 | Pubmed ID: 19779714
Differential MHC class I expression in distinct leukocyte subsets.
BMC immunology , 2011 | Pubmed ID: 21762519
The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.
Breast cancer research : BCR , 2012 | Pubmed ID: 22293321
RAF265 inhibits the growth of advanced human melanoma tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2012 | Pubmed ID: 22351689
INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma.
Cancer research Sep, 2012 | Pubmed ID: 22836752
Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence.
EMBO molecular medicine Jan, 2013 | Pubmed ID: 23180582
Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jul, 2013 | Pubmed ID: 23568779
Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response.
Cancer research Dec, 2014 | Pubmed ID: 25336190
Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells.
Cancer research Jan, 2015 | Pubmed ID: 25398437
Texas Tech University Health Sciences Center
Jon A. Weidanz1,
Krysten L. Doll1,
Soumya Mohana-Sundaram1,
Timea Wichner1,
Devin B. Lowe1,
Susanne Gimlin2,
Debra Wawro Weidanz2,
Robert Magnusson2,3,
Oriana E. Hawkins1
1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center,
2, Resonant Sensors Incorporated,
3, University of Texas Arlington
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.